Iterative Scopes
United States
- Cambridge, Massachusetts
- 19/01/2022
- Series B
- $150,000,000
Iterative Scopes is fast becoming the leader in computational gastroenterology by pioneering the application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug development. Using multi-modal datasets obtained through exclusive partnerships and research collaborations, the company is aggregating the leading training data repository, forming the foundation of its software algorithms. This software fits seamlessly into existing clinical workflows to support physician decision making and clinical trial acceleration. Iterative Scopes is based in Cambridge, Massachusetts and was spun out of MIT in 2017.
- Industry Software Development
- Website https://www.iterativescopes.com/
- LinkedIn https://www.linkedin.com/company/iterative-scopes/about/
Related People
Jonathan NgFounder
United States -
Cambridge, Massachusetts
CEO of Iterative Scopes | Computational Gastroenterology for a better world.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)